Clinical Trial Update: Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating HIPEC as neoadjuvant chemotherapy and postoperative chemotherapy for advanced epithelial ovarian cancer and related gynecolo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Carcinoma

Snippet

Sponsor: Shu-Zhong Cui | Conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Status: UNKNOWN